Hummel, M., Hielscher, T., Emde-Rajaratnam, M., Salwender, H., Beck, S., Scheid, C., . . . Hose, D. (2024). Quantitative integrative survival prediction in multiple myeloma patients treated with bortezomib-based induction, high-dose therapy and autologous stem cell transplantation. JCO precision oncology, 8, . https://doi.org/10.1200/PO.23.00613
Chicago Style (17th ed.) CitationHummel, Manuela, et al. "Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated with Bortezomib-based Induction, High-dose Therapy and Autologous Stem Cell Transplantation." JCO Precision Oncology 8 (2024). https://doi.org/10.1200/PO.23.00613.
MLA (9th ed.) CitationHummel, Manuela, et al. "Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated with Bortezomib-based Induction, High-dose Therapy and Autologous Stem Cell Transplantation." JCO Precision Oncology, vol. 8, 2024, https://doi.org/10.1200/PO.23.00613.